Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
2.9 NOK
45.29 M NOK
152.07 M NOK
8.73 M
About GENTIAN DIAGNOSTICS ASA
Sector
Industry
CEO
Matti Heinonen
Website
Headquarters
Moss
Founded
2001
ISIN
NO0010748866
FIGI
BBG011LPRWH9
Gentian Diagnostics ASA engages in the research, development, production, marketing, and distribution of immunoassays. Its products include GCAL Calprotrectin, Crystatin C, Retinol-Binding Protein, Canine CRP, SARS-CoV-2 Total Ab, NT-proBNP Pre-Launch, BÜHLMANN products, IFU documents, and safety data sheets. The company was founded by Erling M. H. Sundrehagen and Bård Sundrehagen in 2001 and is headquartered in Moss, Norway.
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Related stocks
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange GENTIAN DIAGNOSTICS ASA stocks are traded under the ticker GENTO.
GENTO stock hasn't changed in a week, the last month showed zero change in price, over the last year there was no change in GENTIAN DIAGNOSTICS ASA price.
We've gathered analysts' opinions on GENTIAN DIAGNOSTICS ASA future price: according to them, GENTO price has a max estimate of 67.00 NOK and a min estimate of 67.00 NOK. Watch GENTO chart and read a more detailed GENTIAN DIAGNOSTICS ASA stock forecast: see what analysts think of GENTIAN DIAGNOSTICS ASA and suggest that you do with its stocks.
GENTO stock is 0.00% volatile and has beta coefficient of 0.06. Track GENTIAN DIAGNOSTICS ASA stock price on the chart and check out the list of the most volatile stocks — is GENTIAN DIAGNOSTICS ASA there?
Today GENTIAN DIAGNOSTICS ASA has the market capitalization of 764.95 M, it has increased by 2.67% over the last week.
Yes, you can track GENTIAN DIAGNOSTICS ASA financials in yearly and quarterly reports right on TradingView.
GENTIAN DIAGNOSTICS ASA is going to release the next earnings report on Jul 10, 2025. Keep track of upcoming events with our Earnings Calendar.
GENTO net income for the last quarter is 32.99 M NOK, while the quarter before that showed 3.41 M NOK of net income which accounts for 866.60% change. Track more GENTIAN DIAGNOSTICS ASA financial stats to get the full picture.
Yes, GENTO dividends are paid annually. The last dividend per share was 0.40 NOK. As of today, Dividend Yield (TTM)% is 0.00%. Tracking GENTIAN DIAGNOSTICS ASA dividends might help you take more informed decisions.
As of May 8, 2025, the company has 63 employees. See our rating of the largest employees — is GENTIAN DIAGNOSTICS ASA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENTIAN DIAGNOSTICS ASA EBITDA is 20.09 M NOK, and current EBITDA margin is 11.71%. See more stats in GENTIAN DIAGNOSTICS ASA financial statements.
Like other stocks, GENTO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENTIAN DIAGNOSTICS ASA stock right from TradingView charts — choose your broker and connect to your account.